This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Astrazeneca Ab. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Ulrika Lindblad: Innovator in Pharmaceutical Processes
Introduction
Ulrika Lindblad is a prominent inventor based in Södertälje, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of processes that enhance the purity of chemical compounds. Her work is vital in ensuring the efficacy and safety of pharmaceutical products.
Latest Patents
Ulrika holds 1 patent for her innovative process titled "Process 054." This invention is directed towards the preparation of a diastereomerically pure dibenzoyl-L-tartrate salt of a compound of formula (III). The products derived from this process are essential for various applications in the pharmaceutical industry.
Career Highlights
Ulrika is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her role involves research and development, where she applies her expertise to create advanced pharmaceutical solutions. Her contributions have been instrumental in the company's ongoing projects and innovations.
Collaborations
Ulrika has collaborated with notable colleagues, including Laurent Ducry and Rhony Aufdenblatten. These partnerships have fostered a collaborative environment that enhances the research and development process within AstraZeneca.
Conclusion
Ulrika Lindblad's work exemplifies the impact of innovation in the pharmaceutical industry. Her dedication to developing pure chemical processes contributes significantly to the advancement of medical science.